Global Intra-Uterine Contraceptive Devices Market – Trends and Forecast to 2024
Report Code: HC-R-17-03-DB-184.

Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4.9 billion by 2024, at a CAGR of 3.5% during the forecast period of 2017 to 2024. The report contains 182 pages of exclusive premium insights with 134 tables and 140 figures.

Intra-uterine contraceptive devices are most commonly known as IUDs/IUCDs. These devices are inserted into the uterus by doctors and other healthcare professionals to prevent contraception, by either immobilizing the sperms on their way to the fallopian tubes or by changing the uterine lining, so that the fertilized egg cannot be implanted in it.

Buy Now


Clear selection

"Get Notified On all out New and Upcoming Reports"

       on all the latest research reports

Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4.9 billion by 2024, at a CAGR of 3.5% during the forecast period of 2017 to 2024. The report contains 182 pages of exclusive premium insights with 134 tables and 140 figures.

Intra-uterine contraceptive devices are most commonly known as IUDs/IUCDs. These devices are inserted into the uterus by doctors and other healthcare professionals to prevent contraception, by either immobilizing the sperms on their way to the fallopian tubes or by changing the uterine lining, so that the fertilized egg cannot be implanted in it.

Title

Pages

Price

Cart

BUY FULL REPORT

182

$4200

Buy-Now

Table of Contents

 

 

1 INTRODUCTION

1.1. OVERVIEW OF THE INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET

1.2. MARKET SEGMENTATION & COVERAGE

1.2.1.  CURRENCY AND PRICING

1.2.2.  LIMITATION

1.2.3.  STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1. KEY TAKEAWAYS

2.2. ARRIVING AT THE INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SIZE

2.2.1.           MARKET CRACKDOWN APPROACH

2.2.2.  COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3.  DATA TRIANGULATION

2.2.4.  KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

2.2.6. PORTER’S FIVE FORCES MATRIX

2.4. GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: RESEARCH SNAPSHOT

2.5. ASSUMPTIONS

3 MARKET LANDSCAPE SUMMARY

4 PREMIUM INSIGHTS

4.1. OVERVIEW

4.2. GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: KEY PRIMARY INSIGHTS

4.3. MARKET OVERVIEW

4.3.1.  DRIVERS

4.3.1.1.   INCREASING RATE OF UNPLANNED PREGNANCIES

4.3.1.2.   POPULATION CONTROL POLICIES

4.3.1.3.   RISING INITIATIVES BY THE PRIVATE FIRMS AND NGO’S

4.3.1.4.   FAVOURABLE REIMBURSEMENTS

4.3.1.5.   GROWING AWARENESS OF CONTRACEPTIVE USAGE

4.3.1.6.   GROWING FUNDS AND GRANTS FOR IUCD DEVICES

4.3.1.7.   TECHNOLOGICAL ADVANCEMENTS

4.3.2.  RESTRAINTS

4.3.2.1.   HIGH COST OF TREATMENT

4.3.2.2.   THREAT OF CAUSING PELVIC INFLAMMATORY DISEASES (PID)

4.3.2.3.   THREAT OF ECTOPIC PREGNANCY

4.3.3.  OPPURTUNITIES

4.3.3.1.   INCRESING DEMAND FOR GENERIC INJECTABLES

4.3.4.  THREATS

4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5 EXECUTIVE SUMMARY

6 IUCD MARKET, BY PRODUCT TYPE

6.1. OVERVIEW

6.2. HORMONAL IUCD (2014 – 2022)

6.2.1.  MARKET VALUE (USD MILLION)

6.2.2.  MARKET VOLUME (UNITS SOLD)

6.3. COPPER IUCD (2014 – 2022)

6.3.1.  MARKET VALUE (USD MILLION)

6.3.2.  MARKET VOLUME (UNITS SOLD)

7 IUCD MARKET, BY END USER

7.1. OVERVIEW

7.2. HOSPITALS

7.3. GYNECOLOGY CLINICS

7.4. COMMUNITY HEALTHCARE

 

 

 

8 IUCD MARKET, BY GEOGRAPHY

8.1. COUNTRYWISE INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET,                                                      (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

8.1.1.      NORTH AMERICA

8.1.1.1.      U.S.

8.1.1.2.      CANADA

8.1.1.3.      MEXICO

8.1.2.      EUROPE

8.1.2.1.      GERMANY

8.1.2.2.      FRANCE

8.1.2.3.      U.K.

8.1.2.4.      ITALY

8.1.2.5.      SPAIN

8.1.2.6.      RUSSIA

8.1.2.7.      TURKEY

8.1.2.8.      BELGIUM

8.1.2.9.      NETHERLANDS

8.1.2.10.      SWITZERLAND

8.1.2.11.    REST OF EUROPE

8.1.3.      ASIA-PACIFIC (APAC)

8.1.3.1.      JAPAN

8.1.3.2.      CHINA

8.1.3.3.      SOUTH KOREA

8.1.3.4.      INDIA

8.1.3.5.      AUSTRALIA

8.1.3.6.      SINGAPORE

8.1.3.7.      THAILAND

8.1.3.8.      MALAYSIA

8.1.3.9.      INDONESIA

8.1.3.10.      PHILIPPINES

8.1.3.11.      REST OF APAC

8.1.4.    LATIN AMERICA

8.1.4.1.     BRAZIL

8.1.4.2.     REST OF LATIN AMERICA

8.1.5.    MIDDLE EAST AND AFRICA

8.1.5.1.     SOUTH AFRICA

8.1.5.2.     REST OF MIDDLE EAST AND AFRICA

8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

9 IUCD MARKET: COMPETITIVE LANDSCAPE

9.1. GLOBAL IUCD MARKET: COMPANY SHARE ANALYSIS

9.2. U.S. IUCD MARKET: COMPANY SHARE ANALYSIS

9.3. EUROPE IUCD MARKET: COMPANY SHARE ANALYSIS

9.4. APAC IUCD MARKET: COMPANY SHARE ANALYSIS

9.5. SOUTH AMERICA IUCD MARKET: COMPANY SHARE ANALYSIS

9.6. MIDDLE EAST AND AFRICA  IUCD MARKET: COMPANY SHARE ANALYSIS

9.7. MERGERS & ACQUISITIONS

9.8. NEW PRODUCT DEVELOPMENT & APPROVALS

9.9. EXPANSIONS

9.10. REGULATORY CHANGES

9.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

10 IUCD MARKET, COMPANY PROFILES

10.1 BAYER HEALTHCARE AG

10.1.1   OVERVIEW

10.1.2   SWOT ANALYSIS

10.1.3   PRODUCT PORTFOLIO

10.1.4   REVENUE ANALYSIS

10.1.5   ANALYSTS VIEW

10.2 DKT INTERNATIONAL

10.2.1   OVERVIEW

10.2.2   SWOT ANALYSIS

10.2.3   PRODUCT PORTFOLIO

10.2.4   REVENUE ANALYSIS

10.2.5   ANALYSTS VIEW

10.3 EGEMEN INTERNATIONAL

10.3.1   OVERVIEW

10.3.2   SWOT ANALYSIS

10.3.3   PRODUCT PORTFOLIO

10.3.4   REVENUE ANALYSIS

10.3.5   ANALYST VIEW

10.4 MELBEA AG.

10.4.1   OVERVIEW

10.4.2   SWOT ANALYSIS

10.4.3   PRODUCT PORTFOLIO

10.4.4   REVENUE ANALYSIS

10.4.5   ANALYSTS VIEW

10.5 TEVA PHARMACEUTICALS INDUSTRIES LTD

10.5.1   OVERVIEW

10.5.2   SWOT ANALYSIS

10.5.3   PRODUCT PORTFOLIO

10.5.4   REVENUE ANALYSIS

10.5.5   ANALYSTS VIEW

10.6 ACTAVIS PLC.

10.6.1   OVERVIEW

10.6.2   SWOT ANALYSIS

10.6.3   PRODUCT PORTFOLIO

10.6.4   REVENUE ANALYSIS

10.6.5   ANALYSTS VIEW

10.7 OCON MEDICAL LTD.

10.7.1   OVERVIEW

10.7.2   SWOT ANALYSIS

10.7.3   PRODUCT PORTFOLIO

10.7.4   REVENUE

Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4.9 billion by 2024, at a CAGR of 3.5% during the forecast period of 2017 to 2024. The report contains 182 pages of exclusive premium insights with 134 tables and 140 figures.

Intra-uterine contraceptive devices are most commonly known as IUDs/IUCDs. These devices are inserted into the uterus by doctors and other healthcare professionals to prevent contraception, by either immobilizing the sperms on their way to the fallopian tubes or by changing the uterine lining, so that the fertilized egg cannot be implanted in it.

The Global Intra-Uterine Contraceptive Devices Market has been segmented On the basis of product type the market is segmented into Hormonal IUCD, Copper IUCD.

On the basis of end-user the market is segmented into Hospitals, Gynaecology Clinics, and Community Healthcare.

The global intra uterine contraceptive market is segmented into 5 geographical regions which are North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. The report also includes company share analysis for the major companies operating in this market by major regions global, Europe, North America, Asia Pacific and Rest of the World.

 

Major Players Operating in this market:

DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, Bersil, Amed among other companies.

 

Regions Covered In The Scope Of The Report:

Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA)).